Loading
Latest filing published 23 Feb 2026 for 20/20 Biolabs, Inc.. Read the official filing
No signal scores available.
Only one filing by John G. Compton is known so far (23 February 2026): a transaction, in 20/20 Biolabs, Inc. That is too little to draw conclusions. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration